Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB) (R01 Clinical Trial Optional)
ID: 347224Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB)," aimed at supporting research on the long-term cardiopulmonary effects following tuberculosis (TB) treatment. This initiative seeks applications for epidemiological and observational studies that investigate adverse outcomes and morbidity associated with post-TB lung disease, particularly in both adult and pediatric populations, with a focus on individuals affected by HIV. Understanding the implications of post-TB lung disease is crucial for improving healthcare strategies and patient management for TB survivors. Interested applicants can find more information and submission guidelines at the NIH website, with applications due by May 7, 2026. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a Notice of Funding Opportunity (NOFO) titled "Pulmonary Outcomes and Sequelae after Treatment-TB (POST-TB)." This initiative aims to fund research that explores the long-term cardiopulmonary effects of tuberculosis (TB) treatment, emphasizing studies on both adult and pediatric cohorts, particularly regarding adverse outcomes related to post-TB lung disease (PTLD). Research proposals should focus on understanding the epidemiology, clinical manifestations, and biological mechanisms of PTLD, with an emphasis on individuals affected by HIV. Eligible applicants include higher education institutions, nonprofits, and government agencies, among others. The funding period can extend up to five years, with no budget limitations provided they reflect the project's actual needs. Applications for this grant must adhere strictly to NIH submission guidelines and are due by scheduled deadlines, with a primary goal of reducing the burden of long-term morbidity from TB. Understanding PTLD's impact on healthcare can inform better patient management and treatment strategies, ultimately improving health outcomes for TB survivors.
    Similar Opportunities
    Loading similar opportunities...